MacroGenics
Tracked across 2 events · 13 articles · First seen May 12, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: MacroGenics, Inc. is selling its GMP manufacturing operations and CDMO business to Bora Pharmaceuticals for US$122.5 million, and will sign a long-term CDMO Service Agreement with Bora Pharmaceuticals.
May 12, 2026 · 6 articles
Business
Impact: MacroGenics sold its GMP manufacturing operations to Bora Pharmaceuticals for $122.5 million and entered into a long-term CDMO Service Agreement, which could provide financial benefits and ensure manufacturing support.
Jul 02, 2026 · 7 articles
100
Bora Pharmaceuticals approved acquisition MacroGenicsBora Pharmaceuticals...
80
Bora Pharmaceuticals will sign agreement MacroGenicsBora Pharmaceuticals...
ERGEN INTELLIGENCE
Track MacroGenics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard